secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2024-09-13T23:59:59+00:00
Accession:  0001213900-24-078294
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics CFO resigns; appoints Alexander Epshinsky; boosts ATM capacity to $50M
--------------------------------------------------------------------------------

- Joan Brown resigned as CFO effective Sept 12, 2024; no disagreement with company.
- Alexander Epshinsky appointed CFO effective Sept 12; $340k base salary, $50k signing bonus, $160k RSUs (3-year vest).
- ATM sales agreement second amendment increases placement shares capacity to $50 million.
- Company states it paused financing but now, with new CFO, will pursue financing opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/0001213900-24-078294-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390024078294/ea0214462-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-078294

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer